Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Clinical Efficacy of Erythroid Stimulating Agent (ESA) and Luspatercept (LUSPA) in Vexas Syndrome with or without Myelodysplastic Syndrome (MDS) : A Multicenter Retrospective Study By the Frenvex Group

Mael Heiblig, Vincent Jachiet, Jerome Hadjadj, Lin Pierre Zhao, Thibault Comont, Hervé Lobbes, Valentin Lacombe, Anne Blandine Boutin, Joris Galland, Yesim Dargaud, Benjamin Terrier, Sophie Georgin-Lavialle, Pierre Fenaux, Arsene Mekinian

Blood (2024) 144 (Supplement 1): 2674.

https://doi.org/10.1182/blood-2024-210879

Published: 2024

Journal Articles

Vexas Syndrome Is a New Cause of p53-Mediated Erythroblastopenia

François Rodrigues, Giulia Hardouin, Sara El Hoss, Aya Ghoul, Emilie-Fleur Gautier, Michael Dussiot, Sandy Peltier, Pascal Amireault, Annarita Miccio, Vincent Jachiet, Thiago Trovati Maciel, Sophie Georgin Lavialle, Julien Rossignol, Arsène Mekhinian, Olivier Kosmider, Manuel Rodriguez, Olivier Hermine

Blood (2024) 144 (Supplement 1): 36.

https://doi.org/10.1182/blood-2024-208122

Published: 2024

Journal Articles

Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry

Thibault Comont, Olivier Kosmider, Mael Heiblig, Benjamin Terrier, Didier Bouscary, Guillaume Le Guenno, Roderau Outh, Maxime Samson, Achille Aouba, Estibaliz Lazarro, Odile Rauzy, Lucie Rigolot, Pierre Peterlin, Alexandre Maria, Edouard Flammarion, Alice Garnier, Benoit De Renzis, Shanti Natarajan, Benjamin Carpentier, Marielle Roux-Sauvat, Jose Torregrosa, Fabienne Closs-Prophette, Julien Rossignol, Nicolas Schleinitz, Celine Dieval, Jonahan Broner, Marie-Pierre Gourin, Gaetan Sauvetre, Benoit Faucher, Julien Vinit, Sylvie Grosleron, Alexis Mathian, Louis Terriou, Cyrille Coustal, Philippe Guilpain, Paola Marianetti-Guingel, Holy Bezanahary, Norbert Vey, Bilal Mohty, Thomas Moulinet, Vincent Grobost, Sophie Dimicoli, Benoit Suzon, Antoinette Perlat, Pierre Hirsh, Lise Larcher, Lin Pierre Zhao, Sophie Georgin-Lavialle, Arsene Mekinian, Pierre Fenaux, Vincent Jachiet, French VEXAS study group, Minhemon French Network of immune disorders associated with hemopathies, GFM Groupe Francophone des Myélodysplasies

Blood (2023) 142 (Supplement 1): 4604.

https://doi.org/10.1182/blood-2023-178125

Published: 2023

Journal Articles

Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group

Blood (2023) 142 (Supplement 1): 5599.

https://doi.org/10.1182/blood-2023-178254

Published: 2023

Journal Articles

Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry

Thibault Comont, Maël Heiblig, Jeremie Dion, Etienne Riviere, Louis Terriou, Julien Rossignol, Virginie Rieu, Guillaume Le Guenno, Alexis Mathian, Achille Aouba, Julien Vinit, Benjamin Terrier, Olivier Kosmider, Sophie Georgin-Lavialle, Pierre Fenaux, Arsene Mekinian

Blood (2021) 138 (Supplement 1): 3689.

https://doi.org/10.1182/blood-2021-152363

Published: 2021

Journal Articles

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Blood (2015) 126 (8): 1009–1016.

https://doi.org/10.1182/blood-2014-12-614743

Published: 2015

Includes: Supplemental data

Journal Articles

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Blood (2014) 124 (21): 3254.

https://doi.org/10.1182/blood.V124.21.3254.3254

Published: 2014

Journal Articles

Mast cell leukemia

Sophie Georgin-Lavialle, Ludovic Lhermitte, Patrice Dubreuil, Marie-Olivia Chandesris, Olivier Hermine, Gandhi Damaj

Blood (2013) 121 (8): 1285–1295.

https://doi.org/10.1182/blood-2012-07-442400

Published: 2013

Journal Articles

In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells

Erinn Soucie, Katia Hanssens, Thomas Mercher, Sophie Georgin-Lavialle, Gandhi Damaj, Cristina Livideanu, Maria Olivia Chandesris, Yolène Acin, Sebastien Létard, Paulo de Sepulveda, Olivier Hermine, Olivier A. Bernard, Patrice Dubreuil

Blood (2012) 120 (24): 4846–4849.

https://doi.org/10.1182/blood-2011-12-397588

Published: 2012

Includes: Supplemental data

Journal Articles

Blood CD34 − c-Kit + cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor

Sophie Georgin-Lavialle, Ludovic Lhermitte, Cédric Baude, Stéphane Barete, Julie Bruneau, Jean-Marie Launay, Marie-Olivia Chandesris, Katia Hanssens, Christian de Gennes, Gandhi Damaj, Fanny Lanternier, Mohamed Hamidou, Olivier Lortholary, Patrice Dubreuil, Frédéric Feger, Yves Lepelletier, Olivier Hermine

Blood (2011) 118 (19): 5246–5249.

https://doi.org/10.1182/blood-2011-02-335950

Published: 2011

Journal Articles

Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease

Achille Aouba, Sophie Georgin-Lavialle, Christian Pagnoux, Nicolas Martin Silva, Amédée Renand, Françoise Galateau-Salle, Sophie Le Toquin, Henri Bensadoun, Frederique Larousserie, Stéphane Silvera, Nicole Provost, Sophie Candon, Raphaèle Seror, Mathilde de Menthon, Olivier Hermine, Loïc Guillevin, Boris Bienvenu

Blood (2010) 116 (20): 4070–4076.

https://doi.org/10.1182/blood-2010-04-279240

Published: 2010

NARROW

Clinical Efficacy of Erythroid Stimulating Agent (ESA) and Luspatercept (LUSPA) in Vexas Syndrome with or without Myelodysplastic Syndrome (MDS) : A Multicenter Retrospective Study By the Frenvex Group

Vexas Syndrome Is a New Cause of p53-Mediated Erythroblastopenia

Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry

Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group

Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Mast cell leukemia

In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells

Blood CD34 − c-Kit + cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor

Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only